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A Bifunctional tRNA for In Vitro Selection
pressed in vivo; the cell membrane encapsulates corre-Chuck Merryman,1 Earl Weinstein,1
Stanislaw F. Wnuk,2 and David P. Bartel1,3 sponding protein and nucleic acid sequences during
complex formation. Ribosome display [7] relies on the1Whitehead Institute for Biomedical Research and
Department of Biology integrity of stalled translation complexes to maintain a
link between an mRNA and its protein product. WithMassachusetts Institute of Technology
9 Cambridge Center mRNA display [8, 9], covalent protein-mRNA fusions are
formed on stalled translation complexes; the 3 ends ofCambridge, Massachusetts 02142
2 Department of Chemistry mRNAs are modified in such a way that they stall protein
synthesis, enter the A site of the ribosome, and act likeFlorida International University
Miami, Florida 33199 an aminoacyl tRNA to become attached to their protein
products.
We have been developing an alternative method for
generating libraries of mRNA-encoded peptides, whichSummary
also has the potential to work with other peptide-like
polymers. In our system, a modified tRNA (tRNAx) actsIn vitro selection is a powerful approach for generating
as a bifunctional crosslinking agent to attach an mRNAnovel aptamers and catalysts. Currently, several meth-
to its translation product. For an in vitro selection experi-ods are being developed to extend this technique to
ment to succeed, a molecule with some degree of theproteins. In principle, selection methods could be ap-
desired activity must reside in the initial population, andplied to any library whose members can be replicated.
thus library complexity is critical. Completely in vitroHere, we describe a bifunctional tRNA that fuses
methods like ours, ribosome display [7], and mRNA dis-translation products to their mRNAs. The utility of pep-
play [8, 9] have an advantage over methods that requiretide-tRNA-mRNA fusions for in vitro selection was
the use of cells because library complexity is not limitedillustrated by the selective enrichment of tagged pep-
by transformation efficiency (bacterial transformationtides—together with their mRNAs—by affinity chroma-
currently limits libraries to 109 [10]). In our system, astography. Our system can generate libraries larger
with mRNA display, physically linking a peptide to itsthan 1011. Because library members can be copied and
mRNA by covalent bonds simplifies the purification ofamplified, they provide a means for applying in vitro
peptide-mRNA fusions and increases the range of se-selection procedures to peptides and proteins. Fur-
lectable properties because the integrity of the peptide-thermore, because the system is amenable to transla-
nucleic acid complex is not susceptible to disruption.tion with misacylated tRNAs, a wide range of unusual
Optimized bacterial systems are capable of translatingmonomers could be used to make libraries of nonstan-
about 10% of input mRNAs into protein [11]. Ultimately,dard polymers for selection experiments.
this could increase library complexity and simplify selec-
tions by decreasing the interference from free mRNA.
Introduction Other advantages of bacterial systems involve the ability
to add and subtract specific components. For example,
In vitro selection is regularly used to search libraries of release factors could be removed and suppressor tRNAs
nucleic acids for rare molecules with desirable functions supplied to obviate the need of removing stop codons
[see references 1–4 for reviews]. Molecules with specific from mRNAs [12]. Our system, as with ribosome display,
functions are isolated from libraries with more than 1015 uses E. coli extracts that could take advantage of these
sequences through iterative rounds of selection and am- features. Here, we show that the bifunctional tRNA can
plification; molecules that fulfill the selective criteria in- be used to generate 1011 covalent peptide-tRNAx-mRNA
crease in representation, and amplification increases fusions (PTM fusions) per milliliter of translation reaction
their number. Thus, with each round, the functional mol- and that the fusions can be used to selectively enrich
ecules replace less capable members of the initial popu- and amplify peptide libraries.
lation. Although nucleic acids are endowed with recogni-
tion and catalytic potential, the application of in vitro
selection to polymers with greater chemical diversity Results
would be beneficial. Toward this end, several methods
have been developed to attach peptides and proteins Design and Synthesis of the Bifunctional tRNA
to their encoding DNAs or mRNAs [5–9]. Such fusions We designed a tRNA that can be used to form a stable
contain the essential elements needed for selection and linkage between polypeptides and the mRNA that en-
amplification: a potentially active protein and a corre- codes them. Within the ribosome, the growing peptide
sponding nucleic acid sequence that stores the informa- chain is normally linked to a tRNA by a labile ester bond.
tion needed to make copies of the protein. In phage In turn, the tRNA is transiently linked to the mRNA that
display [5] and plasmid display [6], fusion proteins that encodes the peptide by the base pairs of the codon-
associate with their encoding nucleic acids are ex- anticodon interaction. If the 3-terminal adenosine of an
aminoacyl tRNA is replaced by 3-amino-3-deoxyaden-
osine, the labile ester bond is replaced by a stable amide3 Correspondence: dbartel@wi.mit.edu
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Synthesis of PTM Fusions
PTM fusions were made by translating synthetic mRNAs
(Table 1) in the presence of tRNAx and subsequently
irradiating the translation products with UV light. In the
translation mix, protein synthesis proceeded normally
until a phenylalanine codon (Phe codon) in the mRNA
reached the A site of the ribosome. At this point, either
tRNAx or E. coli tRNAphe could be incorporated. If tRNAx
was selected, it was attached to the translated peptide
chain (formyl-[35S]-MKDYKDDDDK) (Figure 2). No fusion
products were formed if the mRNA did not code for
tRNAx (Figure 2, lane 1). If normal tRNAphe was selected
at a Phe codon, translation continued, as shown by the
production of multiple peptide-tRNA fusions (PT fusions)
with an mRNA that contained multiple Phe codons (Figure
2, lane 2). Because the number of PT fusions produced
was always equal to the number of in-frame Phe codons
in the mRNA, the process was likely the result of normal
translation (Figure 2, lanes 2–5). Furthermore, the mobili-
ties of PT fusions in acrylamide gels were consistent
with the size and charge of the polypeptide encoded by
the translated mRNA (Figure 2, lanes 2–5).
Once linked to the peptide chain, tRNAx stalls protein
synthesis because the ribosome cannot break the amide
bond that connects it to its amino acid [13]. The stalled
ribosomal complexes were stable on sucrose gradients
Figure 1. Design and Synthesis of tRNAx
(data not shown). Therefore, high-salt sucrose cushions
(A) Schematic highlighting the important components of tRNAx. The were used to purify ribosomal complexes from freenitrogen that replaces the 3-terminal oxygen of yeast tRNAphe is
mRNA and ribonucleases. The ribosome-bound PT fu-boxed. The amide bond between the tRNA and phenylalanine is
sions were then linked to their mRNAs by UV irradiationshown as a thick line, and the naturally occurring wybutine base at
position 37 of yeast tRNAphe is labeled (Y). (Figure 3A), which crosslinks the wybutine base in tRNAx
(B) Synthesis of tRNAx. RNAs were resolved on a denaturing 6% to the 5-U of the Phe codon [16] (Figure 3B). As ex-
polyacrylamide gel (PAGE) and visualized with SYBR-gold: lane 1, pected from a process that links a peptide to its mRNA,
total yeast tRNA; lane 2, yeast tRNAphe; lane 3, purified A-yeast the product detected when the peptide was labeledtRNAphe; lane 4, A-yeast tRNAphe repaired with 3-amino-3-deoxy-
comigrated with the product detected when mRNA wasadenosine triphosphate; lane 5, repaired yeast tRNAphe aminoacyl-
labeled (Figure 3A, lanes 4 and 5, respectively). Controlsated with phenylalanine (tRNAx). From top to bottom, the three bands
in lane 2 correspond to the full-length tRNA and truncated forms showed that crosslinking required Phe codons in the
missing the 3-terminal A and CA. mRNA to recruit tRNAx (Figure 3A, lanes 1 and 8), inclu-
sion of tRNAx in the translation mix (Figure 3A, lanes 2
and 7), and exposure to UV light (Figure 3A, lanes 3 and
bond [13]. Similarly, crosslinking the wybutine base (Y 6). Quantitation of the PT and PTM fusion bands (Figure
base) of yeast tRNAphe to the mRNA within the ribosome 3A, lane 4) indicated that about 0.2% of the mRNA was
complex covalently joins the tRNA and mRNA [14]. Thus, decoded by tRNAx and that 1% of the PT fusions formed
a tRNA containing both an amide linkage to its amino PTM fusions. Although the bulk of input mRNA is de-
acid and a Y base (Figure 1A, “tRNAx”) could be useful graded by contaminating ribonucleases, 1011 PTM fu-
for crosslinking proteins to their encoding mRNAs. Yeast sions were made in a 1 ml translation reaction. These
tRNAphe, which contains the Y base, was purified by results open the prospect of using tRNAx to make com-
benzoylated DEAE cellulose chromatography, and tRNA plex pools of mRNA-encoded polypeptides.
missing its 3-terminal adenosine was repaired with
tRNA nucleotidyl transferase and 3-amino-3-deoxy-
adenosine triphosphate (Figure 1B, lanes 1–4). Several Enrichment of Mixed Populations
by Peptide Selectionmethods exist for removing the 3-terminal adenosine
of a tRNA, but with yeast tRNAphe this is generally unnec- Mock in vitro selections were performed to show that
PTM fusions could be used to enrich RNA sequencesessary because the nucleotide is lost during purification
[15]. Once repaired, the modified tRNA contained an that encode peptides with specified properties. In the
first experiment, a synthetic mRNA coding for a Cys-intact acceptor stem with a 3-terminal amine, and it
contained the naturally occurring Y base in the antico- containing peptide and an mRNA coding for six consec-
utive histidines (poly-His) were mixed at a ratio of 1:10.don loop. When the tRNA is aminoacylated with phenyl-
alanine, the amino acid migrates to the 3-amine forming The mRNA mixture was added to a translation reaction
that contained tRNAx, and translated peptides werethe desired amide bond [13]. The tRNA purification, re-
pair, and aminoacylation steps were all efficient (Figure crosslinked to their encoding mRNAs. PTM fusions were
then removed from the ribosome and partially purified1B), and it was not necessary to purify the intermediates
or product. by urea-LiCl precipitation. To selectively isolate PTM
A Bifunctional tRNA for Selections
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Table 1. Sequences of the mRNAs Used to Direct In Vitro Protein Synthesis
mRNA Sequence
1 GGAUCCUAGGAAGCUUGAAGGAGAUAUACCAUG AAA GAC UAC AAG GAC GAC GAC GAC AAG UAU AAA GUU . . .
2 GGAUCCUAGGAAGCUUGAAGGAGAUAUACCAUG AAA GAC UAC AAG GAC GAC GAC GAC AAG UUU UUU UUU . . .
3 GGAUCCUAGGAAGCUUGAAGGAGAUAUACCAUG AAA GAC UAC AAG GAC GAC GAC GAC AAG UUU AAA GUU . . .
4 GGAUCCUAGGAAGCUUGAAGGAGAUAUACCAUG AAA GAC UAC AAG GAC GAC GAC GAC AAG UAU UUU GUU . . .
5 GGAUCCUAGGAAGCUUGAAGGAGAUAUACCAUG AAA GAC UAC AAG GAC GAC GAC GAC AAG UAU AAA UUU . . .
6 GGGUUAACUUUAGAAGGAGGUAAAAAAAAUG AAA CGU GAA AAG ACA UUU UUU UUU
7 GGGUUAACUUUAGAAGGAGGUAAAAAAAAUG AAA CGU GAA AAG ACA GAA CGU ACA
8 GGGUUAACUUUAGAAGGAGGUAAAAAAAAUG AAA CAC CAU CAC CAC CAU CAC GGA AAU CGU UUU UUC UUU
UUC UUU UUC CGC UAG CGU CAG GGC UAU UCA CCA UUA ACC CAC UAG GGC GUU
9 GGGUUAACUUUAGAAGGAGGUAAAAAAAAUG CGU UGC GAU CAC GGA AAU CGU UUU UUC UUU UUC UUU UUC
CGC UAG CGU CAG GGC UAU UCA CCA UUA ACC CAC UAG GGC GUU
10 GGGUUAACUUUAGAAGGAGGUAAAAAAAAUG UUU AAA GAA AAG UUU GAA CGU ACA
For each mRNA, the codons are underlined and the initiator methionine codon (AUG) and Phe codons (UUU or UUC) are in bold. For mRNAs
1–5, part of the sequence is not shown ( . . . ). The remaining sequence is free of phenylalanine codons and is the same as nucleotides 217–444
of -lactamase.
fusions that contained Cys, the purified translation reac- To show that peptide selection was reflected at the
genetic level, the mRNAs contained in the initial andtion was subjected to thiol-affinity chromatography (Fig-
ure 4A). Quantitation of the band intensities from the enriched populations were subjected to RT-PCR and
compared (Figure 4B). When thiol-affinity chromatogra-initial (Figure 4A, lane 1) and selected populations (Fig-
ure 4A, lane 3) indicated that the initially underrepre- phy was used as the selective step, the PCR product
encoding Cys was enriched (Figure 4B, lanes 1–3),sented Cys fusion was enriched about 15-fold. To con-
trol for inadvertent skewing of the makeup of the mixed whereas when metal-affinity chromatography was used,
the PCR product encoding poly-His was enriched (Fig-population by mechanisms other than peptide selection,
we performed the inverse experiment; the mRNA ratio ure 4B, lanes 4–6). Thus, the intended selective step
drives the evolution of the nucleic acid sequences thatwas switched and used to generate a second population
of PTM fusions which were subjected to metal-affinity encode PTM fusions; if another mechanism were domi-
nant—such as preferential RT-PCR amplification of achromatography. Again, the initially underrepresented
fusion—in this case the one containing poly-His—was specific template—the same species would have over-
taken both populations. Because RT-PCR productsenriched, but by about 5-fold (Figure 4A, lanes 4 and 6).
could be used to produce a new population of fusions,
selection and amplification could be repeated to provide
exponential enrichment of target molecules.
Discussion
By fusing a peptide to its mRNA, tRNAx linked corre-
sponding functional and replicable sequences in a single
molecule. Two simple libraries of mRNAs were trans-
lated and fused to their peptide products, and the
mRNAs coding for the selected peptide were amplified.
These results indicate that the system can be used for
the in vitro selection of peptides and proteins from com-
plex libraries.
Library production requires the translation of mRNA
pools that contain randomized coding regions. Phe co-
dons within the randomized region could recruit tRNAx
early, which would produce truncated peptides. How-
ever, selection of a normal tRNAphe at a Phe codon allows
translation to proceed. Thus, by adding tRNAx at a low
effective concentration and placing a large number of
Phe codons after the randomized region, most fusionsFigure 2. Attachment of tRNAx to Growing Peptide Chains
will be formed near the end of an mRNA. Another con-Denaturing 6% PAGE was used to separate the products of in vitro
translation reactions that contained [35S]-methionine and tRNAx. cern is the presence of stop codons in the randomized
Amino acids and peptides bound to normal tRNAs were removed region. Of the existing methods for dealing with this
by base treatment and phenol extraction. Five different mRNAs were problem, perhaps the easiest is to use translation mixes
used to direct translation in an S30 extract (mRNAs 1–5, lanes 1–5,
that contain suppressor tRNAs but no release factorsrespectively). Each of the mRNAs coded for the same leader peptide
[17, 18]. Suppressor tRNAs that are chemically misacyl-(MKDYKDDDDK). Only amino acids specified at codons 11, 12, and
13 differed, as indicated above each lane. ated would have the added advantage of allowing the
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Figure 4. In Vitro Selection of mRNA-Encoded Peptides
(A) Denaturing 4% PAGE of peptide-tRNAx-mRNA fusions before
and after in vitro selection. Two mixtures of mRNA 8 (Cys mRNA)
and mRNA 9 (poly-His mRNA) were translated in the presence of
tRNAx. In mixture X (lanes 1–3), the Cys:poly-His mRNA ratio was
1:10. In mixture Y (lanes 4–6), the mRNA ratio was inverted. Following
translation, PTM fusions were formed and partially purified. The
products of mixture X were selected by thiol-affinity chromatogra-
phy and the products of mixture Y by metal-affinity chromatography.
Lanes 1 and 4, PTM fusions from 1 l of translation; lanes 2 and 5,
column wash from 1 l of translation; lanes 3 and 6, column eluant
from 10 l of translation.
(B) Nondenaturing 8% PAGE analysis of the RT-PCR products pro-
duced from mixture X (lanes 1–3) or Y (lanes 4–6) before and after
in vitro selection by thiol affinity or metal affinity chromatography,
respectively. Lanes 1 and 4, starting mRNA mixtures without reverse
transcriptase; lanes 2 and 5, starting mRNA mixtures; lanes 3 and
6, translated, fused, and selected mRNA mixtures. In both panels,
the mobilities of the Cys- and poly-His-containing PTM fusions or
their RT-PCR products are indicated.
experiments using more highly purified bacterial transla-
Figure 3. PTM Fusions tion systems, over 10 percent of the mRNA is utilized
(A) Denaturing 4% PAGE of the products of in vitro translation reac- for protein synthesis, perhaps because purified systems
tions. Translation reactions contained [35S]-methionine (lanes 1–4)
have less ribonuclease contamination [11]. If still largeror 32P-labeled mRNA (lanes 5–8). In lanes 1 and 8, translation was
libraries are desired, bacterial translation extracts candirected by an mRNA that contained no Phe codons (mRNA 7),
be scaled up without undue expense.whereas the mRNA in lanes 2–7 contained Phe codons at positions
7, 8, and 9 (mRNA 6). Transfer RNAx was not added to lanes 2 and In conjunction with a more highly purified translation
7. Lanes 3 and 6 were not exposed to UV. The mobilities of peptide- system, our method might offer advantages for con-
tRNAx (PT) and peptide-tRNAx-mRNA (PTM) fusions are indicated. structing libraries synthesized from unusual monomers.
The band below the PT fusion in lane 4 probably resulted from
Although all of the systems have the potential to incorpo-UV-dependent degradation of the Y base [29]. In the absence of
rate unnatural amino acids by nonsense suppression,translation, mRNA 7 ran as two separate bands which could also
incorporating unusual monomers at sense codons isaccount for the two PTM fusion products seen in lanes 4 and 5.
(B) Denaturing 6% PAGE of the primer-extension stops for reverse difficult in most other systems. The cognate tRNAs
transcriptase on mRNA 10 that was crosslinked to tRNAx. A, C, G, would need to be specifically eliminated, perhaps by use
and U are dideoxy-sequencing lanes using mRNA as the template. of antisense oligonucleotides, and these tRNAs would
Lane 1, mRNA; lane 2, crosslinking reaction; lane 3, gel-purified
need to be replaced with “orthogonal” tRNAs that arePTM fusions from the crosslinking reaction. The 5-UTR of the mRNA
designed to avoid editing or charging by aminoacyl-and codons 1–4 (MFKE) are indicated.
tRNA synthetases [20]. With our system, such measures
would not be necessary or would be more easily accom-
plished because bacterial translation systems are moreintroduction of unnatural amino acids and other mono-
mers [19, 20]. readily customized. For example, fusions bearing non-
standard polymers have been generated in translationIn a selection experiment, a large population is critical
because it increases the likelihood that desirable mole- mixes that use misacylated tRNA, EFG, and EFTu rather
than total tRNA and S150 (data not shown). In principle,cules are represented. Currently, we can make 1011 fu-
sions in a 1 ml translation reaction, which already sur- ribosome display and mRNA display could use similar
translation systems. However, mRNA display has notpasses the complexity achieved by in vivo methods.
Furthermore, up to a 1000-fold improvement in fusion been shown to work with bacterial ribosomes, and ribo-
some display requires the translation of much longerefficiency might be possible; if fully realized, a 1 ml
reaction would yield 1014 PTM fusions. The bulk of this peptides, as over 40 residues must be translated before
the peptide begins to emerge from the exit channel ofanticipated increase comes from improving crosslinking
efficiency and increased utilization of the mRNA. For the ribosome [7]. With PTM fusions, even short open
reading frames can satisfy the requirements of complex-example, only 0.2 percent of the mRNA was translated
and decoded by tRNAx in our experiments, whereas in ity and accessibility. Thus, because the ribosome can
A Bifunctional tRNA for Selections
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fraction for 30 min at 37C in 30 mM Tris-HCl (pH 7.5), 15 mM MgCl2,use hundreds of monomers [e.g., 21–24], it could be
25 mM KCl, and 5 mM DTT. The final product (tRNAx) was purifiedpossible to build low-molecular-weight libraries that
by phenol extraction and ethanol precipitated.have desirable properties such as protease resistance,
permeability, and conformational rigidity. In conjunction Synthesis of mRNA
with in vitro selection methods, such libraries could open DNA templates for T7 in vitro transcription were generated by PCR,
the door to a vast array of useful molecules that could using appropriate templates and primers. PCR products were etha-
nol precipitated and transcribed in half their original volume (40 mMserve as leads for the development of therapeutics and
Tris-HCl [pH 7.9], 26 mM MgCl2, 2.5 mM spermidine, 0.01% Tritonother useful reagents.
X-100, 5 mM ATP, 5 mM CTP, 8 mM GTP, 2 mM UTP, and T7 RNA
polymerase). All mRNAs (Table 1) were gel purified.
Significance
Synthesis of PT Fusions
We anticipate that the flexibility of our system with Three micrograms of mRNA was translated in 40 l of an E. coli
S30 extract (Promega) according to the manufacturer’s protocol. Inrespect to the types of polymers that could be pro-
addition to exogenous mRNA, reactions contained [35S]-methionineduced will broaden the number of applications to
and 2 M tRNAx. After incubating for 30 min at 37C, the reactionswhich in vitro selection can be applied. In principle,
were terminated by phenol extraction and ethanol precipitated.
fusion libraries that are larger than 1011 could be con- Amino acids and peptides bound to normal tRNAs were removed
structed from any combination of monomers that the by incubation in 0.5 M Ches-KOH (pH 9.5) for 1 hr at 37C, followed
ribosome can polymerize. This large complexity has by phenol extraction and ethanol precipitation.
the potential to generate rare-functional molecules,
Synthesis of PTM Fusionswhile the wide range of acceptable monomers could
For each reaction, translation premix contained 2.5l of 10 transla-be used to adjust the overall physical and chemical
tion buffer (500 mM Tris-acetate [pH 8.0], 110 mM Mg-acetate, 1 Mproperties of a library. Thus, the method could be use-
NH4Cl, and 10 mM DTT); 2.5 l of 100 mM phosphoenol pyruvate;ful for evolving nonbiological polymers whose proper- 0.5 l of 100 mM ATP:10 mM GTP; 0.5 l of 25 g/l total E. coli
ties depart from those accessible to peptides and pro- tRNA; 2.5 l of 1 mM amino acids; 0.5 l of 1 g/l pyruvate kinase;
teins. 3 l of 18 M ribosomes; and 6 l of S150 enzyme fraction. Premix
was incubated for 10 min at 37C, after which 2.5 l of 200 M
tRNAx was added when appropriate. Aliquots (16 l) of the premixExperimental Procedures
were distributed among tubes that contained 2 l of [35S]-methio-
nine-labeled fMet-tRNAMet and 2l of 50M mRNA. When the mRNAPurification of Ribosomes and S150 Enzyme Fraction
rather than the peptide was labeled, the tubes contained 2 l ofFor ribosomes, 5 g of an E. coli ribonuclease-deficient strain (A19)
fMet-tRNAMet and 2 l of 50 M [32P]-cordycepin-labeled mRNA.was washed with 300 ml of buffer A (10 mM Tris-HCl [pH 7.5], 10
Incubation was continued for another 10 min and samples layeredmM Mg-acetate, 22 mM NH4Cl, and 1 mM DTT), pelleted in a Sorvall
onto 500 l sucrose cushions (32% sucrose, 50 mM HEPES [pH 7.8],SLA-3000 rotor (4600 g), and suspended in buffer A in a final volume
20 mM MgCl2, 500 mM NH4Cl, and 6 mM BME). Stalled ribosomalof 20 ml. The suspension was lysed in a BeadBeater mixer (Biospec)
complexes were pelleted by centrifugation for 45 min at 4C in aaccording to the manufacturer’s directions with 80 ml of 0.1 mm
Beckman TLA 100.2 rotor (360,000 g). Pellets were dissolved in 25zirconia/silica beads. The beads were washed several times with
l of buffer (40 mM HEPES [pH 7.8], 20 mM MgCl2, 80 mM NH4Cl,buffer A and the supernatants combined and transferred to 13 ml
and 6 mM BME), spotted on a polystyrene petri dish, covered withcentrifuge tubes. The lysate was cleared by repeated 20 min centrif-
the supplied lid, and exposed to UV for 20 min using a 450 wattugations in a Sorvall SS-34 rotor (17,000 g). Ribosomes were isolated
Hanovia bulb with water jacket (Ace Glass). As before, phenol ex-by layering 13 ml of the clarified supernatant on 13 ml of 32%
traction and base treatment were used to remove undesired transla-sucrose in buffer A and centrifuging for 13 hr in a Beckman 70Ti
tion products.rotor (120,000 g). Pellets were dissolved in a small volume of buffer
A, and the concentration was adjusted to 45 M before storage at
80C in 5–25 l aliquots. For the S150 enzyme fraction, 4 g of cells In Vitro Peptide Selection
was washed in 38 ml of buffer B (10 mM Tris-HCl [pH 7.5], 10 mM PTM fusions were synthesized as described above with minor modi-
MgCl2, 30 mM NH4Cl, and 6 mM BME) and lysed as before but with fications. In brief, [35S]-methionine-labeled fMet-tRNAMet was gener-
buffer B. The lysate was clarified twice by centrifugation for 20 min ated in situ by adding 1/10 (vol/vol) deprotected 5,10-methenyltetra-
in a Sorvall SS-34 rotor (30,000 g) and once for 30 min in a Beckman hydrofolate [28] and 1/10 (vol/vol) [35S]-methionine; the amino acid
VTi50 rotor (150,000 g). The clarified supernatant was loaded on a mix did not contain methionine. To make room for the additional
40 ml DEAE sepharose column (Pharmacia) that had been equili- reagents, half as much amino acid mix was added, concentrated
brated with buffer B, and the column was washed with 1 liter of stocks of nucleotide mix and ribosomes were used, and the final
buffer B. The S150 enzyme fraction was eluted with buffer B plus concentration of tRNAx was reduced to 10M. Rather than individual
220 mM NH4Cl. Fractions were examined by eye, and the dark brown mRNAs, mixtures were used to direct translation; mRNA encoding
ones were pooled and stored at 80C in 20–100 l aliquots. the target peptide was at 0.4 M and mRNA encoding the back-
ground peptide was at 4 M. After crosslinking, ribosomal com-
plexes were mixed 1:1 with lithium buffer (8 M urea, 4 M LiCl, 10Synthesis of the Bifunctional tRNAx
Yeast tRNAphe was purified by benzoylated DEAE cellulose chroma- mM EDTA [pH 8.0], and 6 mM BME) and precipitated overnight at
4C. Pellets were dissolved in 20 mM Tris-HCl (pH 7.5), 2 mM MgCl2,tography [25]. 3-Amino-3-deoxyadenosine triphosphate was pre-
pared by published protocols [26, 27]. The construct pQECCA, ex- 60 mM KCl, and 6 mM BME and stored at 20C. Before selection,
aliquots were precipitated from ethanol and dried by aspiration topressing E. coli tRNA nucleotidyl transferase as a fusion protein
with a poly-His tag, was a generous gift from U. RajBhandary (MIT). remove BME, then dissolved in 10 l of water. Poly-His-containing
fusions from a 90 l translation reaction were bound to Talon metal-Yeast tRNAphe missing its 3-terminal adenosine was repaired by
incubating 500 M tRNA, 2 mM 3-amino-3-deoxyadenosine tri- affinity resin (Clontech) by adding 9 l of the concentrated product
to a resin slurry (100 l resin: 100 l 50 mM Tris-HCl [pH 7.5], 300phosphate, and tRNA nucleotidyl transferase in buffer (50 mM Tris-
HCl [pH 8.0], 10 mM MgCl2, 30 mM KCl, 5 mM DTT, and 0.5 mg/ml mM NH4Cl, and 0.25 mg/ml BSA) and rotating for 16 hr at 4C.
Unbound fusions were removed by washing the resin five times withBSA) for 10 min at 37C. Protein was removed by phenol extraction,
and the tRNA was ethanol precipitated. The intermediate (3-amino- 100 l aliquots of wash buffer (50 mM Tris-HCl [pH 7.5] and 1 M
NH4Cl). Bound fusions were eluted by washing the resin three timestRNAphe) was charged by incubating 25 M 3-amino-tRNAphe, 100
M phenylalanine, and 4 mM dATP with 1/5 (vol/vol) S150 enzyme with 100 l of wash buffer plus 10 mM EDTA (pH 8.0) and 8.3 g
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of total E. coli tRNA. Cys-containing fusions were immobilized in a transfer ribonucleic acid: terminal sequences. J. Biol. Chem.
243, 565–574.similar manner with 500 l of activated Thiol-Sepharose 4B (Phar-
macia) in 5 ml of buffer (25 mM Tris-HCl [pH 7.5], 300 mM NaCl, 16. Steiner, G., Luhrmann, R., and Kuechler, E. (1984). Crosslinking
transfer RNA and messenger RNA at the ribosomal decodingand 7 M urea). After binding, the resin was poured into a column
and washed with 100 ml of the same buffer. The resin was then region: identification of the site of reaction on the messenger
RNA. Nucleic Acids Res. 12, 181–191.removed and eluted three times with 1 ml aliquots of buffer that
also contained 50 mM DTT and 25 g/ml total E. coli tRNA. Column 17. Short, G.F., Golovine, S.Y., and Hecht, S.M. (1999). Effects of
release factor 1 on in vitro protein translation and the elaborationwashes and eluants were ethanol precipitated and dissolved in 90
l or 9 l of water, respectively. For both selections, before RT- of proteins containing unnatural amino acids. Biochemistry 38,
8808–8819.PCR, unfused mRNA was removed from the enriched population of
PTM fusions by gel purification; a liberal section of the gel was 18. Shimizu, Y., Inoue, A., Tomari, Y., Suzuki, T., Yokogawa, T.,
Nishikawa, K., and Ueda, T. (2001). Cell-free translation recon-excised to ensure that gel purification did not influence the ratio of
the two PTM fusions. stituted with purified components. Nat. Biotechnol. 19, 751–755.
19. Heckler, T.G., Chang, L.H., Zama, Y., Naka, T., Chorghade, M.S.,
and Hecht, S.M. (1984). T4 RNA ligase mediated preparation ofAcknowledgments
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unnatural amino acids into proteins. Science 244, 182–188.RajBhandary for plasmid pQECCA. C.M. was supported by a fellow-
21. Bain, J.D., Wacker, D.A., Kuo, E.E., and Chamberlin, A.R. (1991).ship from the National Institutes of Health.
Site-specific incorporation of nonnatural residues into pep-
tides—effect of residue structure on suppression and transla-
Received: March 4, 2002 tion efficiencies. Tetrahedron 47, 2389–2400.
Revised: April 24, 2002 22. Mendel, D., Ellman, J., and Schultz, P.G. (1993). Protein-biosyn-
Accepted: April 24, 2002 thesis with conformationally restricted amino-acids. J. Am.
Chem. Soc. 115, 4359–4360.
23. Thorson, J.S., Cornish, V.W., Barrett, J.E., Cload, S.T., Yano,References
T., and Schultz, P.G. (1998). A biosynthetic approach for the
incorporation of unnatural amino acids into proteins. Meth. Mol.1. Gold, L., Polisky, B., Uhlenbeck, O., and Yarus, M. (1995). Diver-
Biol. 77, 43–73.sity of oligonucleotide functions. Annu. Rev. Biochem. 64,
24. Hohsaka, T., Kajihara, D., Ashizuka, Y., Murakami, H., and Si-763–797.
sido, M. (1999). Efficient incorporation of nonnatural amino acids2. Lorsch, J.R., and Szostak, J.W. (1996). Chance and necessity
with large aromatic groups into streptavidin in in vitro proteinin the selection of nucleic acid catalysts. Acc. Chem. Res. 29,
synthesizing systems. J. Am. Chem. Soc. 121, 34–40.103–110.
25. Gillam, I., Millward, S., Blew, D., von Tigerstrom, M., Wimmer,3. Kurz, M., and Breaker, R.R. (1999). In vitro selection of nucleic
E., and Tener, G.M. (1967). The separation of soluble ribonucleicacid enzymes. Curr. Top. Microbiol. Immunol. 243, 137–158.
acids on benzoylated diethylaminoethylcellulose. Biochemistry4. Bartel, D.P., and Unrau, P.J. (1999). Constructing an RNA world.
6, 3043–3056.Trends Cell Biol. 9, M9–M13.
26. Robins, M.J., Hawrelak, S.D., Hernandez, A.E., and Wnuk, S.F.5. Smith, G.P. (1985). Filamentous fusion phage: novel expression
(1992). Nucleic-acid related-compounds. 71. Efficient general-vectors that display cloned antigens on the virion surface. Sci-
synthesis of purine (amino, azido, and triflate)-sugar nucleo-ence 228, 1315–1317.
sides. Nucleosides Nucleotides 11, 821–834.6. Cull, M.G., Miller, J.F., and Schatz, P.J. (1992). Screening for
27. Morr, M., and Wray, V. (1994). New cyclic-derivatives ofreceptor ligands using large libraries of peptides linked to the
3-amino-3-deoxyadenosine-5-diphosphate, 3-amino-3-C terminus of the lac repressor. Proc. Natl. Acad. Sci. USA 89,
deoxyadenosine-5-triphosphate, and 3-amino-3-deoxyaden-1865–1869.
osine-5-methylenebis(phosphonate). Angew. Chem. Int. Ed. 33,7. Mattheakis, L.C., Bhatt, R.R., and Dower, W.J. (1994). An in vitro
1394–1396.polysome display system for identifying ligands from very large
28. Blanquet, S., Dessen, P., and Kahn, D. (1984). Properties andpeptide libraries. Proc. Natl. Acad. Sci. USA 91, 9022–9026.
specificity of methionyl-tRNAfMet formyltransferase from Esch-8. Nemoto, N., Miyamoto-Sato, E., Husimi, Y., and Yanagawa, H.
erichia coli. Methods Enzymol. 106, 141–152.(1997). In vitro virus: bonding of mRNA bearing puromycin at
29. Matzke, A.J., Barta, A., and Kuechler, E. (1980). Photo-inducedthe 3-terminal end to the C-terminal end of its encoded protein
crosslinking between phenylalanine transfer RNA and messen-on the ribosome in vitro. FEBS Lett. 414, 405–408.
ger RNA on the Escherichia coli ribosome. Eur. J. Biochem.9. Roberts, R.W., and Szostak, J.W. (1997). RNA-peptide fusions
112, 169–178.for the in vitro selection of peptides and proteins. Proc. Natl.
Acad. Sci. USA 94, 12297–12302.
10. Noren, K.A., and Noren, C.J. (2001). Construction of high-com-
plexity combinatorial phage display peptide libraries. Methods
23, 169–178.
11. Pavlov, M.Y., and Ehrenberg, M. (1996). Rate of translation of
natural mRNAs in an optimized in vitro system. Arch. Biochem.
Biophys. 328, 9–16.
12. Cho, G., Keefe, A.D., Liu, R., Wilson, D.S., and Szostak, J.W.
(2000). Constructing high complexity synthetic libraries of long
ORFs using in vitro selection. J. Mol. Biol. 297, 309–319.
13. Fraser, T.H., and Rich, A. (1973). Synthesis and aminoacylation
of 3-amino-3-deoxy transfer RNA and its activity in ribosomal
protein synthesis. Proc. Natl. Acad. Sci. USA 70, 2671–2675.
14. Matzke, A.J., Barta, A., and Kuechler, E. (1980). Mechanism of
translocation: relative arrangement of tRNA and mRNA on the
ribosome. Proc. Natl. Acad. Sci. USA 77, 5110–5114.
15. RajBhandary, U.L., Stuart, A., Hoskinson, R.M., and Khorana,
H.G. (1968). Studies on polynucleotides. 78. Yeast phenylalanine
